Table 1.

A list of chemicals used for the screening

Group	Chemical	Name	Dose used	Activity	Reference
I	clinically approved or under clinical development	steroid (deflazacort)	∼0.1–1 μM	clinically used. anti-inflammation.	Griggs et al.25
		NHE1 inhibitor (rimeporide)	∼1–10 μM	Na+/H+ exchanger inhibitor	Previtali et al.26 and Ghaleh et al.27
		BGP-15	∼1–10 μM	poly (ADP-ribose) polymerase inhibitor	Kennedy et al.28
		idebenone	∼1–10 μM	antioxidant	Buyse et al.29
		dantrolene	1 μM	muscle relaxant	Krause et al.30
		GsMTx4 (AT-300)	1 μM	mechanosensitive channel blocker	Ward et al.31
II	commercially available	2-APB	1 μM	Ca2+ modulator	Maruyama et al.32
		5J4	10 μM	Ca2+ modulator	N/A
		ML9	10 μM	Ca2+ modulator	Wu et al.33
		creatine	100 μM	organic compound	Felber et al.34 and Tarnopolsky et al.35
		Rycal S107	10 μM	Ca2+ modulator	Capogrosso et al.36
		SKF 96365	10 μM	Ca2+ modulator	Esteve et al.37
		IGF-I	100 nM	growth factor	Vandenburgh et al.38
		YM 58483	10 μM	Ca2+ modulator	Olah et al.39
		MRS1845	10 μM	Ca2+ modulator	N/A
		Ochratoxin A	10 μM	SERCA-ATP-Ca2+ pump stimulator	Fernandez-Tenorio et al.40
		istaroxime	10 μM	Na+/K+ ATPase inhibitor	Huang41